Correction to: Design,Synthesis,Radiolabeling,and Biologic Evaluation of Three 18 F-FDG-Radiolabeled Targeting Peptides for the Imaging of Apoptosis,by Khoshbakht S,Beiki D,Geramifar P,et al. Cancer Biother Radiopharm 2019;34(5):271–279. DOI: 10.1089/cbr.2018.2709

In the June 2019 issue of Cancer Biotherapy and Radiopharmaceuticals (vol. 34, no. 5; 271–279), the article titled Design, Synthesis, Radiolabeling, and Biologic Evaluation of Three ₁₈F-FDG-Radiolabeled Targeting Peptides for the Imaging of Apoptosis by Sepideh Khoshbakht, et al., incorrectly listed Danial Shamshirian's affiliation as:

“PET/CT Center, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.”

The correct affiliation should have appeared as:

Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

The online version of the article has been corrected.

The authors apologize for the error.